Wang Ting, Xiang Qian, Bian Jinjun
Department of Anesthesiology, Changhai Hospital, Second Military Medical University/Naval Medical University, Shanghai 200433, China.
J Intensive Med. 2021 May 27;1(2):99-102. doi: 10.1016/j.jointm.2021.05.001. eCollection 2021 Oct.
The novel coronavirus disease 2019 (COVID-19) pandemic is a worldwide catastrophe, thoroughly challenging the healthcare systems. A growing number of victims suffer from a remarkable acute respiratory distress syndrome (ARDS) that necessitates admission to the intensive care unit (ICU), but there are no satisfactory treatments. Various gas therapies including nitric oxide, ozone, hyperbaric oxygen, hydrogen, and heliox have been employed in the fight against the pandemic and have improved clinical outcomes. However, the potential roles of these gases in COVID-19 treatment need to be verified in well-designed randomized controlled trials. This paper reviews advances in gaseous therapy of COVID-19.
2019年新型冠状病毒病(COVID-19)大流行是一场全球性灾难,给医疗系统带来了巨大挑战。越来越多的患者患有严重的急性呼吸窘迫综合征(ARDS),需要入住重症监护病房(ICU),但目前尚无令人满意的治疗方法。包括一氧化氮、臭氧、高压氧、氢气和氦氧混合气在内的各种气体疗法已被用于抗击这一疫情,并改善了临床结局。然而,这些气体在COVID-19治疗中的潜在作用需要在精心设计的随机对照试验中得到验证。本文综述了COVID-19气体疗法的进展。